Among them, four genes, including APOL1, CCL17, RBP4, and KRT71 were selected in real-time PCR experiments between tumor samples and normal samples, which were found to be consistent with the expression trend in low- and high-risk groups. The gene discussed is CCL17; the disease is neoplasm.